[HTML][HTML] Quantifizierung von Ki-67 in PitNET („pituitary neuroendocrine tumors “)/Adenomen

J Klein, K Saeger, W Saeger - Die Pathologie, 2024 - Springer
Die vorliegende Studie vergleicht erstmals die Bestimmung des Ki-67-Index bei PitNET/
Hypophysenadenomen durch Pathologen mit einer computergestützten Methode (Cognition …

[PDF][PDF] TP53 and SF3B1 mutations in pituitary tumours

JF Simon - 2024 - edoc.ub.uni-muenchen.de
The pituitary gland is the master gland of the endocrine system controlling diverse functions,
such as growth, metabolism and reproduction. It is situated in the sella turcica of the …

Immunotherapy and Endocrine Oncology

M Contreras, JC Sánchez, P Iglesias - Handbook of Cancer and …, 2022 - Springer
Cancer immunotherapy is a new form of therapy that enhance the immune system to control
growth and proliferation of tumor cells. Therapy with immune checkpoint inhibitor (ICI) …

Increased matrix stiffness in pituitary neuroendocrine tumors invading the cavernous sinus is activated by CAFs through the mTOR pathway

T Xie, Y Gao, J Hu, R Luo, Y Guo, Q Xie, C Yan, Y Tang… - 2024 - researchsquare.com
Purpose Pituitary neuroendocrine tumors (PitNETs) with invasion of the cavernous sinus
(CS) are particularly challenging to treat. Cancer associated fibroblasts (CAFs) are …

Cathepsin K promotes bone invasion of pituitary adenomas via interacting with TLR4 to mediate RANKL expression

H Liu, G Wang, P Wang, J Zhao, W Han, Y Mu, W Gu - 2024 - researchsquare.com
Purpose: This study aimed to explore the regulation and mechanism of Cathepsin K (CTSK)
in bone invasive pituitary adenomas (BIPAs). Experimental Design: A total of 1437 patients …

Petroclival Aggressive Pituitary Adenoma in Nelson's Syndrome: 2-Dimensional Operative Video

S Serioli, I Borghesi, NR Gianas… - Operative …, 2023 - journals.lww.com
Nelson's syndrome (corticotroph tumor progression after bilateral adrenalectomy/Nelson
syndrome) is a complication that occurs in 8% to 47% of cases following bilateral total …

Reassessing the Reliability of Ki-67 as an Indicator of Pituitary Neuroendocrine Tumor Progression: Based on Cell Lineage Categorization

Q Ye, J Nie, D Wu, J Peng, K Wang, M Zhou, Y Xing… - 2024 - researchsquare.com
Background: The role of KI-67, a tumor proliferation marker, as a biomarker for progression
in pituitary neuroendocrine tumors (PitNETs) remains controversial. The aim of this study …

Agresszív hypophysisadenoma és hypophysiscarcinoma= Aggressive pituitary adenoma and pituitary carcinoma

M Tóth - Orvosi hetilap, 2023 - real.mtak.hu
A régen jóindulatú tumorként számontartott hypophysisdaganatok ritkán agresszíven
viselkednek, és metasztázist is adhatnak. Az Európai Endokrinológiai Társaság aktuális …

Aggressive Pituitary Adenomas

G Raverot - The Pituitary, 2022 - Elsevier
Although usually benign, pituitary tumors sometimes exhibit an aggressive behavior, with
the invasion of surrounding tissues, resistance to conventional treatments, and frequent …

Cathepsin K promotes bone invasion of pituitary adenomas via mediating adenoma cell proliferation and osteoclastogenesis

H Liu, P Wang, J Zhao, W Han, Y Mu, W Gu - 2024 - researchsquare.com
Cathepsin K promotes bone invasion of pituitary adenomas via mediating adenoma cell
proliferation and osteoclastogenesis | Research Square Research Square Browse Preprints …